大承气汤联合穴位超声导入疗法治疗危重症腹内高压临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R278

基金项目:

温州市科技局课题(Y20210560)


Clinical Study on Dachengqi Decoction Combined with Point Ultrasound Introduction Therapy for Severe Intra-Abdominal Hypertension
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察大承气汤联合穴位超声导入疗法治疗危重症腹内高压的临床疗效。方法:选取50 例危 重症腹内高压患者作为研究对象,按照随机数字表法分为对照组和观察组各25 例。在常规西医治疗的基础 上,对照组加用大承气汤治疗,观察组加用大承气汤联合穴位超声导入疗法治疗。观察2 组康复指标、急性生 理及慢性健康状况评分(APCHEⅡ)、急性胃肠损伤分级(AGI)、营养风险筛查量表评分、中医证候评分以及 不良反应发生率。结果:治疗后,观察组腹内压、排便频率、腹围均低于对照组(P<0.05),ICU 住院时间及 机械通气时间均短于对照组(P<0.05)。治疗后3、5、7 d,2 组APCHEⅡ评分均较治疗后1 d 降低(P< 0.05),并呈下降趋势(P<0.05);且观察组APCHEⅡ评分在同时间点均低于对照组(P<0.05)。治疗后, 2 组AGI 分级均较治疗前改善(P<0.05),观察组AGI 分级优于对照组(P<0.05)。治疗后3、5、7 d,2 组营 养风险筛查量表评分均较治疗后1 d 降低(P<0.05),并呈下降趋势(P<0.05);且观察组营养风险筛查量表 评分在同时间点均低于对照组(P<0.05)。治疗后,2 组腹部胀满、腹痛、发热、呕吐、口干口臭、大便干结 等中医证候评分均较治疗前降低(P<0.05),且观察组各项评分均低于对照组(P<0.05)。治疗后,观察组不 良反应发生率为8.00%,对照组为12.00%,2 组比较,差异无统计学意义(P>0.05)。结论:大承气汤联合穴 位超声导入疗法治疗危重症腹内高压能够促进患者病情康复,有效改善急性胃肠损伤,提高患者健康及营养状 况,且安全性良好。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Dachengqi Decoction combined with point ultrasound introduction therapy on severe intra- abdominal hypertension. Methods:A total of 50 cases of patients with severe intra-abdominal hypertension were selected as the study objects and divided into the control group and the observation group according to the random number table method,with 25 cases in each group. Based on routine western medicine treatment,the control group was additionally treated with Dachengqi Decoction, and the observation group was additionally treated with Dachengqi Decoction combined with point ultrasound introduction therapy. Rehabilitation indexes,Acute Physiology and Chronic Health Evaluation Ⅱ (APCHE Ⅱ) scores, Acute Gastrointestinal Injury (AGI) grading, nutritional risk screening,traditional Chinese medicine (TCM) syndrome scores and the incidence of adverse reactions in the two groups were observed. Results: After treatment, intra- abdominal pressure, defecation frequency and abdominal circumference in the observation group were lower than those in the control group (P<0.05),the length of ICU stay and the duration of mechanical ventilation were shorter than those in the control group (P<0.05). On day 3,5 and 7 after treatment,the APCHEⅡ scores in the two groups were decreased when compared with those on day 1 after treatment (P<0.05) and showed a decreasing trend (P<0.05);the APCHEⅡ scores in the observation group were lower than those in the control group at the same time point (P<0.05). After treatment, the AGI grading in the two group were improved when compared with those before treatment (P<0.05),and the AGI grading in the observation group was better than that in the control group (P<0.05). On day 3,5 and 7 after treatment,the scores of nutritional risk screening in the two groups were decreased when compared with those on day 1 after treatment (P<0.05) and showed a decreasing trend (P<0.05);the scores of nutritional risk screening in the observation group were lower than those in the control group at the same time point P<0.05). After treatment,the scores of TCM syndromes including abdominal distension,abdominal pain,fever,vomiting,dry mouth,halitosis, and dry stool in the two groups were decreased when compared with those before treatment (P<0.05), and the above scores in the observation group were lower than those in the control group (P<0.05). After treatment, the incidence of adverse reactions was 8.00% in the observation group and 12.00% in the control group, there being no significant difference between the two groups (P>0.05). Conclusion: Dachengqi Decoction combined with point ultrasonic introduction therapy can promote the rehabilitation of patients with severe intra- abdominal hypertension , effectively improve the acute gastrointestinal injury and enhance the health and nutritional status of patients,with good safety.

    参考文献
    相似文献
    引证文献
引用本文

温正旺,郑建,郑玲玲,陶真.大承气汤联合穴位超声导入疗法治疗危重症腹内高压临床研究[J].新中医,2024,56(4):146-150

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-02-28
  • 出版日期:
文章二维码